ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in BIOA — BioAge Labs, Inc.
CIK 1164508
BOSTON, MA
Position in BIOA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,214,347
-$322,691 QoQ
Shares Held
49,545
-43.6% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 151 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. BIOA ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,137,442 | $225,456,582 | |
| 2 | VTRS |
Viatris Inc
|
8,371,218 | $132,934,941 | |
| 3 | HLN |
Haleon plc
|
14,181,817 | $132,316,352 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,642,086 | $67,374,788 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
957,514 | $61,233,020 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,732,924 | $59,838,771 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
562,016 | $46,523,684 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,872,157 | $46,073,783 |
All Filings in BIOA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,214,347 | 49,545 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,537,038 | 87,881 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||